Monash University
Amy Wilson_PhD Thesis_final.pdf (38.98 MB)

Improving in vivo detection methods and immunotherapies for epithelial ovarian cancer

Download (38.98 MB)
posted on 2020-04-02, 04:19 authored by AMY LOUISE WILSON
Epithelial ovarian cancers (EOCs) are the most lethal of all female reproductive-associated cancers. The immune system plays a significant role in the progression of EOC, thus therapies that can re-activate the anti-tumour immune response are promising; however, improved animal models are required in order to accurately assess new therapies effectively. We developed a new ovarian cancer mouse model that permits tracking of ovarian cancer progression non-invasively in real time. We used this model to show that a type 2 diabetes drug can restore the immune response and delay ovarian cancer progression, both alone and in combination with chemotherapy. This exciting work will hopefully lead to a new treatment for ovarian cancer.


Principal supervisor


Additional supervisor 1

Dr. Andrew Stephens

Additional supervisor 2

A/Prof. Mark Wright

Additional supervisor 3

Dr. Kirsty Wilson

Year of Award


Department, School or Centre

Central Clinical School

Additional Institution or Organisation

Immunology - Alfred

Campus location



Doctor of Philosophy

Degree Type



Faculty of Medicine, Nursing and Health Sciences